BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24980553)

  • 1. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors.
    Gong C; Nie Y; Qu S; Liao JY; Cui X; Yao H; Zeng Y; Su F; Song E; Liu Q
    Cancer Res; 2014 Aug; 74(16):4341-52. PubMed ID: 24980553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.
    Nie Y; Chen J; Huang D; Yao Y; Chen J; Ding L; Zeng J; Su S; Chao X; Su F; Yao H; Hu H; Song E
    Cancer Res; 2017 Jul; 77(13):3605-3618. PubMed ID: 28512246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs are differentially deregulated in mammary malignant phyllodes tumour.
    Tsang JY; Ni YB; Ng EK; Shin VY; Mak KF; Go EM; Tawasil J; Chan SK; Ko CW; Kwong A; Tse GM
    Histopathology; 2015 Sep; 67(3):294-305. PubMed ID: 25585495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of miR-145 in cardiac myofibroblast differentiation.
    Wang YS; Li SH; Guo J; Mihic A; Wu J; Sun L; Davis K; Weisel RD; Li RK
    J Mol Cell Cardiol; 2014 Jan; 66():94-105. PubMed ID: 24001939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
    Kim GE; Kim NI; Park MH; Lee JS
    Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
    Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
    Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein expression and gene mutation in phyllodes tumors of the breast.
    Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
    Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7.
    Liu J; Zhou Y; Shi Z; Hu Y; Meng T; Zhang X; Zhang S; Zhang J
    DNA Cell Biol; 2016 Sep; 35(9):521-9. PubMed ID: 27303812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phyllodes tumor of the breast: an update.
    Tse GM; Niu Y; Shi HJ
    Breast Cancer; 2010; 17(1):29-34. PubMed ID: 19434472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
    Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
    Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
    Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
    Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
    Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
    Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
    Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
    Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
    Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
    Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phyllodes tumor of the breast: role of CD10 in predicting metastasis.
    Al-Masri M; Darwazeh G; Sawalhi S; Mughrabi A; Sughayer M; Al-Shatti M
    Ann Surg Oncol; 2012 Apr; 19(4):1181-4. PubMed ID: 22006372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression.
    Butti R; Nimma R; Kundu G; Bulbule A; Kumar TVS; Gunasekaran VP; Tomar D; Kumar D; Mane A; Gill SS; Patil T; Weber GF; Kundu GC
    Oncogene; 2021 Mar; 40(11):2002-2017. PubMed ID: 33603163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
    Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
    Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.
    Ang MK; Ooi AS; Thike AA; Tan P; Zhang Z; Dykema K; Furge K; Teh BT; Tan PH
    Breast Cancer Res Treat; 2011 Sep; 129(2):319-29. PubMed ID: 20945089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
    Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.